Asset

AMINOLEVULINIC ACID HYDROCHLORIDE

Biofrontera Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (1)

ApplicationTypeApplicant
NDA 208081NDABIOFRONTERA INC

Marketed products (1)

  • AMELUZ